Lantheus Holdings, Inc. Operating Expenses
Lantheus Holdings, Inc. (LNTH) reported Operating Expenses of $142.96 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-02-25
- Lantheus Holdings, Inc. operating expenses for the quarter ending 2016-03-31 was $21.86M, a 10.39% decline year-over-year.
- Lantheus Holdings, Inc. operating expenses for the quarter ending 2015-12-31 was $20.99M, a 0.19% decline year-over-year.
- Lantheus Holdings, Inc. operating expenses for the quarter ending 2015-09-30 was $20.30M, a 9.46% decline year-over-year.
- Lantheus Holdings, Inc. operating expenses for the quarter ending 2015-06-30 was $27.31M, a 29.56% increase year-over-year.
- Lantheus Holdings, Inc. operating expenses for fiscal 2020 was $142.96M, a 16.09% increase from fiscal 2019.
- Lantheus Holdings, Inc. operating expenses for fiscal 2019 was $123.15M, a 11.55% increase from fiscal 2018.
- Lantheus Holdings, Inc. operating expenses for fiscal 2018 was $110.40M, a 0.10% increase from fiscal 2017.
- Lantheus Holdings, Inc. operating expenses for fiscal 2017 was $110.28M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2020-12-31 | $142.96M 10-K · filed 2021-02-25 | |||
| 2019-12-31 | $123.15M 10-K · filed 2021-02-25 | |||
| 2018-12-31 | $110.40M 10-K · filed 2021-02-25 | |||
| 2017-12-31 | $110.28M 10-K · filed 2020-02-25 | |||
| 2016-03-31 | $21.86M 10-Q · filed 2016-05-03 | $42.85M derived: sum of 2 quarters · filed 2016-05-03 | $63.15M derived: sum of 3 quarters · filed 2016-05-03 | $90.46M derived: sum of 4 quarters · filed 2016-05-03 |
| 2015-12-31 | $20.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02 | $41.29M derived: sum of 2 quarters · filed 2016-03-02 | $68.60M derived: sum of 3 quarters · filed 2016-03-02 | $92.99M 10-K · filed 2016-03-02 |
| 2015-09-30 | $20.30M 10-Q · filed 2015-11-04 | $47.61M derived: sum of 2 quarters · filed 2015-11-04 | $72.00M 10-Q · filed 2015-11-04 | $93.03M derived: sum of 4 quarters · filed 2016-05-03 |
| 2015-06-30 | $27.31M 10-Q · filed 2015-08-05 | $51.70M 10-Q · filed 2015-08-05 | $72.74M derived: sum of 3 quarters · filed 2016-05-03 | $95.15M derived: sum of 4 quarters · filed 2016-05-03 |
| 2015-03-31 | $24.39M 10-Q · filed 2016-05-03 | $45.42M derived: sum of 2 quarters · filed 2016-05-03 | $67.84M derived: sum of 3 quarters · filed 2016-05-03 | $88.92M derived: sum of 4 quarters · filed 2016-05-03 |
| 2014-12-31 | $21.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02 | $43.45M derived: sum of 2 quarters · filed 2016-03-02 | $64.53M derived: sum of 3 quarters · filed 2016-03-02 | $86.10M 10-K · filed 2016-03-02 |
| 2014-09-30 | $22.42M 10-Q · filed 2015-11-04 | $43.50M derived: sum of 2 quarters · filed 2015-11-04 | $65.07M 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $21.08M 10-Q · filed 2015-08-05 | $42.65M 10-Q · filed 2015-08-05 | ||
| 2013-12-31 | $96.25M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |